Shopping Cart
Remove All
Your shopping cart is currently empty
AE-3763 is a peptide-based inhibitor of human neutrophil elastase with an IC50 of 29 nM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | Inquiry | 3-6 months | 3-6 months | |
| 50 mg | Inquiry | 3-6 months | 3-6 months | |
| 100 mg | Inquiry | 3-6 months | 3-6 months |
| Description | AE-3763 is a peptide-based inhibitor of human neutrophil elastase with an IC50 of 29 nM. |
| Targets&IC50 | Neutrophil elastase (human):29 nM |
| In vitro | AE-3763 has potent inhibitory activity against human neutrophil elastase as well as extremely high solubility and stability in water. |
| In vivo | The infusion of AE-3763 significantly inhibits edema and leukocyte infiltration into the lung and improves the survival rate by 24 hours in a mouse model of fatal shock with multiple organ dysfunction. AE-3763 dose-dependently prevents hemorrhage when administered intravenously by infusion (ED50: 0.42 mg/kg/h) or bolus injection (1.2 mg/kg). Preliminary studies indicate no overt toxic effects of AE-3763 (300 mg/kg, i.v.) in mice. |
| Animal Research | D-Galactosamine shock is induced in C3H/HeN mice (6-7 w, 22-25 g). AE-3763 (10 or 100 mg/kg) is administrated intraperitoneally six times at 2 h interval. Control animals receive the vehicle (PBS) instead of AE-3763. The animal survival rate is observed up to 24 h after shock induction. |
| Molecular Weight | 549.54 |
| Formula | C23H34F3N5O7 |
| Cas No. | 291778-77-3 |
| Smiles | CC(C)[C@H](NC(=O)CN1CCN(CC(O)=O)C1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)C(F)(F)F |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.